Solubilized lectin-purified extracts from human monocyte-like cells (U-937) and freshly isolated human mononuclear cells preincubated in the presence of phorbol 12-myristate 13-acetate (PMA) stimulated phosphorylation of synthetic tyrosine-containing polymers and of casein. Tyrosine phosphorylation was confirmed by phospho amino acid analysis. PMA stimulated phosphorylation of exogenous substrates in a time-and concentration-dependent manner. This phosphorylation reaction did not require addition of phospholipid, diolein, or calcium. Biologically inactive phorbol compounds did not stimulate phosphorylation in this system. In addition, PMA enhanced phosphorylation of a Mr 140,000 protein as well as several other endogenous proteins in the U-937 extracts. PMA treatment stimulated predominantly phosphorylation on tyrosine residues of the Mr 140,000 protein. Tyrosine phosphorylation, typical of growth-promoting peptides such as insulin or epidermal growth factor, is believed to play a role in regulating normal and disordered cellular growth and proliferation. The demonstration of PMA-stimulated tyrosine phosphorylation might provide a clue to the mechanism of cellular differentiation and proliferation induced by the tumor promoter.
PMA enhanced phosphorylation of a Mr 140,000 protein as well as several other endogenous proteins in the U-937 extracts. PMA treatment stimulated predominantly phosphorylation on tyrosine residues of the Mr 140,000 protein. Tyrosine phosphorylation, typical of growth-promoting peptides such as insulin or epidermal growth factor, is believed to play a role in regulating normal and disordered cellular growth and proliferation. The demonstration of PMA-stimulated tyrosine phosphorylation might provide a clue to the mechanism of cellular differentiation and proliferation induced by the tumor promoter.
Phosphorylation-dephosphorylation reactions are important mechanisms for regulating protein functions. Ligands as diverse as the tumor-promoting phorbol esters, polypeptide hormones, and growth factor peptides are involved in cellular phosphorylation events of at least a superficial similarity. The potent tumor-promoting phorbol esters bind to some cellular constituent, a "receptor," which has been found to purify with a protein kinase activity (protein kinase C) (1, 2) . Protein kinase C is a serine and threonine kinase that has been isolated from rat brain (3) . Similarly, for epidermal growth factor (EGF) (4), insulin (5) , platelet-derived growth factor (6) , and some onc gene products (7) , the receptor-protein kinase activity and the kinase substrate are on the same protein or proteins that are very closely associated. These growth peptides induce, however, predominantly tyrosine phosphorylations.
Two events are of interest with respect to insulin and phorbol 12-myristate 13-acetate (PMA) action on the U-937 monocyte-like cell: (i) insulin stimulates phosphorylation of the 95,000-dalton subunit of the U-937 insulin receptor, and this same preparation contains a kinase activity that phosphorylates exogenous substrates such as casein and specific tyrosine-containing synthetic copolymers (8) ; (ii) PMA, the most potent tumor promoter, has a major effect on the affinity of insulin for its receptor in the U-937 cell and the IM-9 lymphocytes as well as of EGF for its receptor on HeLa cells (9) (10) (11) (12) .
To investigate further possible links between PMA and the growth peptides we have examined the effect of PMA on (i) phosphorylation of exogenously added substrates, including tyrosine-containing peptides, and (ii) phosphorylation of endogenous substrates in U-937 extracts. We found that PMA, like the various growth factor peptides, stimulates phosphorylation of tyrosine residues.
MATERIALS AND METHODS
Materials. The following materials were purchased from Sigma: PMA, 4a-phorbol 12,13-didecanoate (4a-PD2), phorbol 12,13-diacetate (PA2), 4a-phorbol, casein, poly(Glu80- Source of Kinase. Human monocyte-like cells (U-937) were cultured in RPMI-1640 medium supplemented with Lglutamine and 10% newborn calf serum (GIBCO). The cell suspension was divided 1:3 and supplemented with fresh medium every 3 days. Cells in late logarithmic phase of growth were harvested by centrifugation at 600 X g for 10 min at 4°C. Alternatively, 100 ml of blood was drawn from normal human volunteers and centrifuged through a Ficoll-Hypaque gradient (13) to yield a mononuclear cell layer. Cells were washed three times in buffer containing 0.25 M sucrose, 50 mM Hepes, 1 mM phenylmethylsulfonyl fluoride, and aprotinin at 1 ,g/ml. After homogenization in a glass homogenizer, particulate components were removed by a 5-min centrifugation at 600 x g at 4°C. The supernatant was centrifuged at 190,000 x g for 2 hr and the resulting pellet was solubilized in 50 mM Hepes/1% Triton X-100/1 mM phenylmethylsulfonyl fluoride for 1 hr at 4°C. The suspension was centrifuged at 120,000 x g for 1 hr and the supernatant was then passed four times through a column containing wheat-germ agglutinin coupled to agarose (Miles (Fig. 1) . Four other tyrosine-containing copolymers showed little or no stimulation of phosphorylation by PMA. This stimulation did not correlate with the relative tyrosine content of these substrates. Other unknown qualitative features of these peptides must determine their ability to serve as substrates of tyrosine-specific kinases.
To confirm directly that only the tyrosine residues of these peptides were phosphorylated, phospho amino acid analysis of the phosphorylated substrate was carried out. Phosphotyrosine was the sole phospho amino acid detected when the copolymer (G,T) was used (Fig. 2) . Addition of PMA (0.3 ,uM) increased the phosphotyrosine content approximately 2-fold, which was comparable to the stimulation measured in the standard phosphorylation assay (Fig. 1) .
To further characterize the PMA-stimulated kinase(s), The numerous in vitro effects of phorbol ester derivatives have correlated thus far with their tumor-promoting activities. Four non-tumor-promoting compounds related to PMA (phorbol, 4a-phorbol, PA2 and PD2) failed to stimulate casein phosphorylation in our assay (Fig. 3) proteins were analyzed by NaDodSO4/polyacrylamide gel electrophoresis under reducing conditions and autoradiography. PMA stimulated, in a time-dependent fashion, phosphorylation of several proteins (Fig. 5) . To determine the phospho amino acid content of the predominant phosphorylated protein, the band at Mr 140,000 was excised from the gel, the protein was electroeluted and subjected to acid hydrolysis, and phospho amino acid analysis was performed. The regions of the plate corresponding to the three phospho amino acids were scraped and their 32p contents were determined. Preincubation with PMA caused an 8-fold increase of the phosphotyrosine content of the Mr 140,000 protein (Fig.  6 ). In addition, a smaller increase was seen in the phosphoserine (3-fold) and phosphothreonine (2-fold) contents of the band derived from the sample treated with PMA. DISCUSSION Our study shows that the tumor-promoting phorbol ester PMA stimulates activity of tyrosine kinase from extracts of both human cultured monocytes and mononuclear blood cells. PMA increases phosphotyrosine content of both tyrosine-containing artificial substrates and proteins such as casein. In addition, PMA stimulates the phosphorylation of predominantly a Mr 140,000 protein in a wheat-germ agglutinin-purified extract of U-937 monocyte cells. Phospho amino acid analysis of this phosphoprotein revealed predominantly phosphotyrosine.
The mechanism of PMA-induced phosphorylation cannot be directly determined from our data. We have suggested (18) . Stimulation of membrane-associated kinases, especially the phospholipiddependent protein kinase C, is now thought to initiate action of bioactive phorbol esters.
In intact U-937 cells, PMA markedly and rapidly inhibits binding of insulin to its receptor at 37TC (9) (10) (11) . The binding subunit of the insulin receptor (a subunit) has an apparent molecular weight of 125,000-135,000 by several criteria (19) . Preliminary studies indicate that PMA-stimulated phosphorylation of the Mr 140,000 protein persists after immunoprecipitation with human autoantibodies to the insulin receptor. This is insufficient evidence, however, to show identity of this protein and the a subunit of the insulin receptor. The possible relationship between PMA-stimulated phosphorylation of the Mr 140,000 protein and PMA inhibition of insulin binding remains unclear.
Regardless of the identification of the Mr 140,000 phosphoprotein, the data indicate that under the conditions of our study PMA stimulated its phosphorylation on tyrosine residues. In this respect PMA is analogous to insulin, which stimulates tyrosine phosphorylation of the 8 (8 1ul) of samples (after lyophilization) were applied at the origin. Because of the PMA-stimulated phosphorylation of the Mr 140,000 band, the amounts of 32P contained in the samples derived from the basal (324 cpm) and PMA-treated (808 cpm) were different. The dried gel was autoradiographed for 14 days. The spots corresponding to the individual amino acids were scraped afterwards from the plates and their 32p contents were determined. The ratio of radioactivity from the PMAstimulated vs. basal samples was 8.2 for phosphotyrosine, 3.2 for phosphoserine, and 2.4 for phosphothreonine.
ine and threonine phosphorylations also occur. It is possible that serine and threonine phosphorylations are catalyzed by protein kinase C; the usual cofactors for this reaction may not be required in an impure plasma membrane preparation. Whether the tyrosine, serine, and threonine phosphorylations are completely independent events or related in some fashion is unclear at present.
In summary, this study demonstrates further analogy between two seemingly diverse systems, the growth factors and the tumor-promoting phorbol esters. The action of growth-stimulating peptides (insulin, EGF, platelet-derived growth factor, and onc gene products) involves an integrated receptor-protein kinase-autophosphorylation mechanism thought to mediate both normal and abnormal cell growth. A special feature of these systems is a tyrosine-specific phosphorylation. The tumor-promoting phorbol esters, which are also involved in the induction of cell proliferation, are shown here to stimulate a tyrosine-specific phosphorylation. Whether there is a further interrelationship between the PMA-stimulated tyrosine kinase activity and the ability of the phorbol ester to modulate insulin and EGF binding to their receptors remains to be determined.
Since the original submission of our manuscript four rele- 
